SHG:688298 - Zhejiang Orient Gene Biotech Co Ltd

Zhejiang Orient Gene Biotech C
Sector: Health Care, Industry: Health Care Equipment

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2016 Q4	2017 Q4	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	8.82B 63.6%	9.57B 8.5%	10.17B 6.3%	12.68B 24.7%	10.9B -14.0%	10.63B -2.5%	8.77B -17.5%	4.4B -49.8%	2.16B -50.9%	1.56B -27.6%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.9B 60.1%	2.19B 15.2%	2.67B 21.6%	3.84B 44.2%	4.32B 12.5%	4.46B 3.1%	4.31B -3.2%	2.84B -34.2%	1.61B -43.2%	1.23B -23.6%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	6.92B 64.6%	7.37B 6.6%	7.5B 1.8%	8.84B 17.8%	6.58B -25.6%	6.17B -6.2%	4.45B -27.8%	1.56B -65.0%	546.62M -64.9%	330.75M -39.5%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.15B 59.6%	3.56B 13.2%	4.29B 20.3%	5.59B 30.5%	6.04B 8.0%	6.18B 2.4%	5.65B -8.7%	3.87B -31.4%	2.35B -39.3%	1.98B -15.6%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.24B 58.7%	1.37B 10.2%	1.62B 18.3%	1.75B 8.1%	1.72B -2.1%	1.73B 0.5%	1.33B -22.8%	1.03B -22.4%	737.36M -28.7%	752.08M 2.0%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.67B 65.9%	6B 5.8%	5.88B -2.0%	7.08B 20.4%	4.86B -31.4%	4.44B -8.5%	3.12B -29.8%	525.48M -83.2%	-190.74M -	-421.33M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.56B -	-	4.94B -	-	4.32B -	-	2.1B -	-	-641.12M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.55B 61.3%	4.93B 8.5%	4.92B -0.2%	5.8B 17.9%	4.27B -26.4%	4.05B -5.0%	2.07B -49.0%	-49.3M -	-639.12M -	-1.06B -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	22.738 60.5%	24.643 8.4%	24.405 -1.0%	28.768 17.9%	14.43 -49.8%	12.321 -14.6%	10.258 -16.7%	-4.342 -	-5.892 -	-8.262 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	22.738 60.5%	24.643 8.4%	24.405 -1.0%	28.768 17.9%	14.43 -49.8%	12.321 -14.6%	10.258 -16.7%	-4.342 -	-5.892 -	-8.262 -